JINEL PATEL: Open Payments
NPI 1164003273 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 87 payments from 18 companies in 2025. Trend: 2023 $2,466 · 2024 $3,009 · 2025 $1,724
Food & beverage: $1,634Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $311 |
| Novartis Pharmaceuticals Corporation | 12 | $309 |
| Janssen Biotech, Inc. | 8 | $205 |
| Amgen Inc. | 5 | $180 |
| PFIZER INC. | 9 | $148 |
| Galderma Laboratories, L.P. | 6 | $103 |
| Arcutis Biotherapeutics, Inc. | 6 | $96 |
| Lilly USA, LLC | 3 | $53 |
| Organon LLC | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $50 |
Products named: SKYRIZI, TREMFYA, COSENTYX, Otezla, CIBINQO, Zoryve, NEMLUVIO, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
